Avidity Partners Management LP Seagen Inc. Transaction History

Avidity Partners Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $14.1 Million - $18.8 Million	-104,500 Reduced 19.0%	445,500 $61 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $49 Million - $80.7 Million	450,000 Added 450.0%	550,000 $97.3 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $70 Million - $92.3 Million	-585,000 Reduced 85.4%	100,000 $14.4 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $21.1 Million - $28.2 Million	148,000 Added 27.56%	685,000 $106 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $14.7 Million - $17.5 Million	-103,000 Reduced 16.09%	537,000 $91.2 Million

Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $8.39 Million - $10 Million	62,100 Added 10.75%	640,000 $101 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $79.5 Million - $110 Million	577,900 New	577,900 $80.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.